{"gene":"MCCC2","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2001,"finding":"The human MCCB (MCCC2) gene, located on chromosome 5q13 and comprising 17 exons, encodes the 563-amino acid non-biotin-containing beta-subunit of 3-methylcrotonyl-CoA carboxylase (MCC). Missense mutations in MCCB (R268T and E99Q) cause an almost total loss of MCC enzyme activity in fibroblasts, establishing MCCC2 as a disease-causing gene for 3-methylcrotonyl-CoA carboxylase deficiency.","method":"cDNA cloning, chromosomal mapping, Sanger sequencing of patient alleles, enzyme activity assay in fibroblasts","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 — original cloning with direct enzyme activity measurement in patient fibroblasts","pmids":["11406611"],"is_preprint":false},{"year":2003,"finding":"Missense mutations in MCCB (MCCC2) at evolutionarily conserved residues cause null or severely diminished MCC carboxylase activity when expressed by transient transfection in SV40-transformed MCC-deficient fibroblasts, directly confirming their pathogenicity. Structural homology modelling to E. coli acetyl-CoA carboxylase biotin carboxylase subunit was used to rationalise the effect of MCCA mutations, indicating the MCC holoenzyme shares conserved active-site architecture.","method":"Transient transfection of patient-derived missense mutations into MCC-deficient fibroblasts, MCC enzyme activity assay, 3D homology modelling","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 1 — functional rescue/loss assay in relevant cell system with direct enzymatic readout","pmids":["14680978"],"is_preprint":false},{"year":2012,"finding":"Crystal structures of MCC holoenzyme (containing both MCCC1/alpha and MCCC2/beta subunits) revealed an unanticipated domain architecture including previously unrecognized domains, and provided a molecular basis for understanding the two-step carboxylation catalytic mechanism of the biotin-dependent carboxylase as well as the structural basis for a large collection of disease-causing mutations in the MCCC2 beta (carboxyltransferase) subunit.","method":"Crystal structure determination of MCC holoenzyme, structure-function analysis of disease mutations","journal":"Cellular and molecular life sciences : CMLS","confidence":"High","confidence_rationale":"Tier 1 — crystallographic structure of MCC holoenzyme with mechanistic and mutational validation, review of multiple structures","pmids":["22869039"],"is_preprint":false},{"year":2021,"finding":"MCCC2 promotes hepatocellular carcinoma (HCC) cell proliferation, migration, and invasion in vitro and tumor growth in vivo. MCCC2 supports leucine metabolism: HCC cells lacking MCCC2 fail to respond to leucine deprivation (proliferation/migration inhibition seen in MCCC2-present but not MCCC2-absent cells), and MCCC2 knockdown reduces glycolysis markers (glucose consumption, lactate secretion) and acetyl-CoA levels. Mass spectrometry-based interactome profiling revealed MCCC2-associated proteins enriched in protein metabolism and energy pathways. MCCC2 promotes ERK activation.","method":"MCCC2 sgRNA knockout, siRNA knockdown, CCK-8 proliferation assay, transwell migration/invasion assay, flow cytometry, xenograft in vivo, leucine deprivation experiments, mass spectrometry interactome profiling, western blot for ERK, metabolite measurements","journal":"Cancer cell international","confidence":"Medium","confidence_rationale":"Tier 2 — KO/KD with defined cellular phenotypes and metabolic readouts in vitro and in vivo, but ERK activation mechanistic link is indirect","pmids":["33407468"],"is_preprint":false},{"year":2023,"finding":"MCCC2 forms a protein complex with the telomere-binding protein TRF2, as shown by co-immunoprecipitation. MCCC2 knockdown or knockout reduces mitochondrial numbers (without affecting gross ATP production), upregulates mitochondrial fusion markers MFN1, MFN2, and OPA1 (indicating increased mitochondrial fusion), and reduces telomere length without affecting telomerase (TERT) expression or activity, identifying MCCC2 as a novel mediator between mitochondria and telomeres.","method":"Co-immunoprecipitation (MCCC2/TRF2 complex), MCCC2 KD/KO in colorectal cancer cells, transmission electron microscopy (mitochondrial morphology), western blot (MFN1, MFN2, OPA1, TERT), telomere length measurement, telomerase activity assay, xenograft in vivo","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP interaction with TRF2 and multi-phenotype KD/KO characterization, single lab","pmids":["37828426"],"is_preprint":false},{"year":2024,"finding":"ECHDC2 promotes ubiquitination and proteasomal degradation of MCCC2 protein by physically binding the E3 ubiquitin ligase NEDD4, which ubiquitinates MCCC2. This degradation of MCCC2 suppresses the P38 MAPK pathway, reducing aerobic glycolysis and proliferation in gastric cancer cells. Co-immunoprecipitation confirmed the ECHDC2–NEDD4–MCCC2 ternary interaction.","method":"Co-immunoprecipitation (ECHDC2, NEDD4, MCCC2), western blot (ubiquitination assay, P38 MAPK pathway), ECHDC2 overexpression in gastric cancer cells, colony formation/CCK8/EDU proliferation assays, glucose/lactic acid assays, subcutaneous tumor experiments in nude mice, immunofluorescence","journal":"Molecular medicine (Cambridge, Mass.)","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP of ternary complex with ubiquitination assay and functional pathway readout, single lab","pmids":["38783226"],"is_preprint":false},{"year":2025,"finding":"SIRT4 directly deacetylates MCCC2 at lysine 269 (K269), which promotes formation of a stable MCCC1/MCCC2 heterodimeric complex with robust MCC enzymatic activity, leading to increased acetyl-CoA production. This elevated acetyl-CoA results in increased H3K27 acetylation and stem cell-like (tumor-initiating cell) properties and invasiveness in HCC cells. SIRT4 expression is upregulated by α2δ1-mediated calcium signaling.","method":"Deacetylation assay (SIRT4 acting on MCCC2-K269), co-immunoprecipitation (MCCC1/MCCC2 complex stability), acetyl-CoA measurement, H3K27 acetylation assay, tumor-initiating cell sphere assays, invasion assays, in vivo tumor growth assay, site-directed mutagenesis (K269 acetylation site)","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 1-2 — direct PTM identification with mutagenesis and multiple functional readouts, single lab","pmids":["40384857"],"is_preprint":false},{"year":2026,"finding":"MCCC2 knockdown in triple-negative breast cancer (TNBC) cells inhibits proliferation, migration, invasion, and tumor growth. The inhibitory effect of MCCC2 knockdown is reversed by rapamycin (mTOR inhibitor) and abolished under leucine-free culture conditions, indicating that MCCC2 promotes TNBC progression by activating mTOR signaling in a leucine-dependent manner.","method":"MCCC2 siRNA knockdown in TNBC cell lines, proliferation/migration/invasion assays, xenograft tumor growth, rapamycin combination treatment, leucine deprivation experiments, bioinformatic pathway analysis (CPTAC database)","journal":"Breast cancer (Dove Medical Press)","confidence":"Medium","confidence_rationale":"Tier 2-3 — KD with pharmacological and nutrient-deprivation epistasis establishing leucine-mTOR axis, single lab","pmids":["41836158"],"is_preprint":false}],"current_model":"MCCC2 (MCCB) encodes the non-biotin-containing beta (carboxyltransferase) subunit of the mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC) heterodimer, which catabolizes leucine; its enzymatic activity depends on formation of a stable complex with the MCCC1 alpha-subunit (promoted by SIRT4-mediated deacetylation at K269), and MCCC2 drives cancer cell proliferation and invasion by sustaining leucine-dependent acetyl-CoA production, mTOR signaling, and ERK activation, while being subject to NEDD4-mediated ubiquitin-proteasomal degradation facilitated by ECHDC2, and additionally interacting with telomere-binding protein TRF2 to influence mitochondrial dynamics and telomere maintenance."},"narrative":{"teleology":[{"year":2001,"claim":"Identification of MCCC2 as the gene encoding the beta subunit of MCC and demonstration that its mutations cause 3-methylcrotonyl-CoA carboxylase deficiency established the molecular basis of this inborn error of leucine metabolism.","evidence":"cDNA cloning, chromosomal mapping, Sanger sequencing of patient alleles, and MCC enzyme activity assay in fibroblasts","pmids":["11406611"],"confidence":"High","gaps":["Structural basis of how beta-subunit mutations disrupt holoenzyme function was unknown","Regulation of MCCC2 protein levels and post-translational modifications were uncharacterized"]},{"year":2003,"claim":"Functional expression of patient-derived MCCC2 missense mutations in MCC-deficient fibroblasts directly confirmed their pathogenicity and showed that conserved residues in the carboxyltransferase subunit are essential for catalytic activity.","evidence":"Transient transfection of mutant MCCC2 into SV40-transformed MCC-deficient fibroblasts with direct MCC enzyme activity readout","pmids":["14680978"],"confidence":"High","gaps":["No high-resolution structure of the holoenzyme was available to map mutation effects","Genotype–phenotype correlations across the full mutation spectrum remained incomplete"]},{"year":2012,"claim":"Crystal structures of the MCC holoenzyme revealed the domain architecture of the MCCC2 beta subunit and provided a structural framework for the two-step carboxylation mechanism and for rationalizing disease-causing mutations.","evidence":"X-ray crystallography of the MCCC1–MCCC2 holoenzyme with structure–function analysis of known mutations","pmids":["22869039"],"confidence":"High","gaps":["Post-translational regulation of complex assembly was not addressed","Non-catalytic roles of MCCC2 in cellular signaling were unknown"]},{"year":2021,"claim":"Demonstrating that MCCC2 promotes hepatocellular carcinoma cell proliferation, invasion, and ERK activation through leucine metabolism and acetyl-CoA production expanded its role beyond a housekeeping enzyme to an oncogenic metabolic node.","evidence":"MCCC2 KO/KD in HCC cells, xenograft models, leucine deprivation epistasis, metabolite measurements, mass spectrometry interactome, ERK western blot","pmids":["33407468"],"confidence":"Medium","gaps":["Direct mechanism linking MCCC2-derived acetyl-CoA to ERK activation was not delineated","Whether the oncogenic role is generalizable across tumor types was untested"]},{"year":2023,"claim":"Discovery of a physical MCCC2–TRF2 complex and the finding that MCCC2 loss reduces mitochondrial numbers and telomere length suggested an unexpected role linking mitochondrial dynamics to telomere maintenance.","evidence":"Co-immunoprecipitation of MCCC2 and TRF2, MCCC2 KD/KO in colorectal cancer cells, TEM for mitochondrial morphology, telomere length measurement","pmids":["37828426"],"confidence":"Medium","gaps":["Co-IP was performed in a single lab without reciprocal validation from an independent group","Mechanism by which MCCC2 influences telomere length independently of telomerase is unknown","Whether TRF2 interaction requires MCCC2 enzymatic activity was not tested"]},{"year":2024,"claim":"Identification of NEDD4 as the E3 ligase that ubiquitinates MCCC2 — facilitated by ECHDC2 as an adaptor — established the first defined mechanism for MCCC2 protein turnover and linked MCCC2 stability to P38 MAPK-dependent aerobic glycolysis in gastric cancer.","evidence":"Co-immunoprecipitation of ECHDC2–NEDD4–MCCC2 ternary complex, ubiquitination assays, ECHDC2 overexpression in gastric cancer cells, in vivo xenografts","pmids":["38783226"],"confidence":"Medium","gaps":["Specific ubiquitination sites on MCCC2 were not mapped","Whether NEDD4-mediated degradation operates in non-cancer tissues is unknown"]},{"year":2025,"claim":"SIRT4-mediated deacetylation of MCCC2 at K269 was shown to promote stable MCCC1–MCCC2 complex formation, increasing MCC activity, acetyl-CoA output, and downstream H3K27 acetylation that drives tumor-initiating cell properties in HCC.","evidence":"In vitro deacetylation assay, K269 site-directed mutagenesis, co-IP for complex stability, acetyl-CoA and H3K27ac measurements, sphere-forming and invasion assays, in vivo tumor growth","pmids":["40384857"],"confidence":"Medium","gaps":["Whether K269 acetylation status regulates MCCC2 stability via the NEDD4 pathway was not examined","Physiological relevance of SIRT4-MCCC2 axis in normal leucine catabolism remains untested"]},{"year":2026,"claim":"Epistasis experiments in triple-negative breast cancer demonstrated that MCCC2-driven proliferation depends on leucine availability and mTOR signaling, consolidating the leucine–mTOR axis as the dominant oncogenic mechanism downstream of MCCC2.","evidence":"MCCC2 siRNA KD in TNBC cells, rapamycin rescue, leucine-free culture abrogation of phenotype, xenograft tumor growth","pmids":["41836158"],"confidence":"Medium","gaps":["Direct biochemical link between MCCC2-derived metabolites and mTOR activation (e.g., leucine sensing machinery) is not resolved","Contribution of MCCC2 catalytic activity versus scaffolding functions to mTOR activation is unclear"]},{"year":null,"claim":"The integration of MCCC2 post-translational regulation (SIRT4 deacetylation versus NEDD4 ubiquitination) with its non-canonical roles in telomere maintenance and mitochondrial dynamics remains mechanistically unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No reconstitution of the MCCC2–TRF2 axis in a non-cancer or physiological model","How MCCC2 K269 acetylation cross-talks with NEDD4-mediated ubiquitination is unknown","Structural basis for non-catalytic protein–protein interactions of MCCC2 is lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,2,6]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,2,4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,3,6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3,5,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,7]}],"complexes":["3-methylcrotonyl-CoA carboxylase (MCCC1–MCCC2 heterodimer)"],"partners":["MCCC1","SIRT4","TRF2","NEDD4","ECHDC2"],"other_free_text":[]},"mechanistic_narrative":"MCCC2 encodes the non-biotin-containing carboxyltransferase (beta) subunit of mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC), which catalyzes an essential step in leucine catabolism and whose crystal structure reveals a conserved two-step carboxylation mechanism [PMID:22869039]. Missense mutations in MCCC2 abolish MCC enzyme activity and cause 3-methylcrotonyl-CoA carboxylase deficiency [PMID:11406611, PMID:14680978]. Formation of a catalytically competent MCCC1–MCCC2 heterodimer is promoted by SIRT4-mediated deacetylation of MCCC2 at K269, linking leucine-derived acetyl-CoA production to H3K27 acetylation and tumor-initiating cell properties, while MCCC2 protein turnover is governed by NEDD4-mediated ubiquitin-proteasomal degradation facilitated by ECHDC2 [PMID:40384857, PMID:38783226]. In cancer cells, MCCC2 sustains proliferation and invasion through leucine-dependent activation of mTOR and ERK signaling pathways and influences mitochondrial dynamics and telomere length via interaction with TRF2 [PMID:33407468, PMID:41836158, PMID:37828426]."},"prefetch_data":{"uniprot":{"accession":"Q9HCC0","full_name":"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial","aliases":["3-methylcrotonyl-CoA carboxylase 2","3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit","3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta"],"length_aa":563,"mass_kda":61.3,"function":"Carboxyltransferase subunit of the 3-methylcrotonyl-CoA carboxylase, an enzyme that catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA, a critical step for leucine and isovaleric acid catabolism","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/Q9HCC0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MCCC2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MCCC2","total_profiled":1310},"omim":[{"mim_id":"609014","title":"3-@METHYLCROTONYL-CoA CARBOXYLASE 2; MCCC2","url":"https://www.omim.org/entry/609014"},{"mim_id":"609010","title":"3-@METHYLCROTONYL-CoA CARBOXYLASE 1; MCCC1","url":"https://www.omim.org/entry/609010"},{"mim_id":"210210","title":"3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D","url":"https://www.omim.org/entry/210210"},{"mim_id":"210200","title":"3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D","url":"https://www.omim.org/entry/210200"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":109.5}],"url":"https://www.proteinatlas.org/search/MCCC2"},"hgnc":{"alias_symbol":["MCCB","MCCCβ"],"prev_symbol":[]},"alphafold":{"accession":"Q9HCC0","domains":[{"cath_id":"3.90.226.10","chopping":"66-292","consensus_level":"high","plddt":97.6645,"start":66,"end":292},{"cath_id":"3.90.226.10","chopping":"313-471_518-548","consensus_level":"high","plddt":97.8889,"start":313,"end":548}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCC0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCC0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCC0-F1-predicted_aligned_error_v6.png","plddt_mean":94.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MCCC2","jax_strain_url":"https://www.jax.org/strain/search?query=MCCC2"},"sequence":{"accession":"Q9HCC0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HCC0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HCC0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCC0"}},"corpus_meta":[{"pmid":"16835865","id":"PMC_16835865","title":"Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment.","date":"2006","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16835865","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19494832","id":"PMC_19494832","title":"How the MccB bacterial ancestor of ubiquitin E1 initiates biosynthesis of the microcin C7 antibiotic.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19494832","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11406611","id":"PMC_11406611","title":"Cloning of the human MCCA and MCCB genes and mutations therein reveal the molecular cause of 3-methylcrotonyl-CoA: carboxylase deficiency.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11406611","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30026096","id":"PMC_30026096","title":"Biosynthesis and characterization of polyhydroxyalkanoate from marine Bacillus cereus MCCB 281 utilizing glycerol as carbon source.","date":"2018","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30026096","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22264772","id":"PMC_22264772","title":"A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency.","date":"2011","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22264772","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27868364","id":"PMC_27868364","title":"Production and characterization of polyhydroxybutyrate from Vibrio harveyi MCCB 284 utilizing glycerol as carbon source.","date":"2016","source":"Journal of applied microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/27868364","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33407468","id":"PMC_33407468","title":"MCCC2 promotes HCC development by supporting leucine oncogenic function.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33407468","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38783226","id":"PMC_38783226","title":"ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/38783226","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14680978","id":"PMC_14680978","title":"Functional analysis of MCCA and MCCB mutations causing methylcrotonylglycinuria.","date":"2003","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/14680978","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32302772","id":"PMC_32302772","title":"Marine actinomycetes Nocardiopsis alba MCCB 110 has immunomodulatory property in the tiger shrimp Penaeus monodon.","date":"2020","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32302772","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37828426","id":"PMC_37828426","title":"MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer.","date":"2023","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/37828426","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33548322","id":"PMC_33548322","title":"Biocompatibility of polyhydroxybutyrate-co-hydroxyvalerate films generated from Bacillus cereus MCCB 281 for medical applications.","date":"2021","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33548322","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28401470","id":"PMC_28401470","title":"Streptomyces artemisiae MCCB 248 isolated from Arctic fjord sediments has unique PKS and NRPS biosynthetic genes and produces potential new anticancer natural products.","date":"2017","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/28401470","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21071250","id":"PMC_21071250","title":"Novel mutations in the human MCCA and MCCB gene causing methylcrotonylglycinuria.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21071250","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17465309","id":"PMC_17465309","title":"Synechocystis MCCB 114 and 115 as putative probionts for Penaeus monodon post-larvae.","date":"2007","source":"Diseases of aquatic organisms","url":"https://pubmed.ncbi.nlm.nih.gov/17465309","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34015495","id":"PMC_34015495","title":"A novel substituted derivative of sterol from marine actinomycetes Nocardiopsis alba MCCB 110 antagonistic to the aquaculture pathogen Vibrio harveyi.","date":"2021","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/34015495","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24617020","id":"PMC_24617020","title":"Potential application of beta-1, 3 glucanase from an environmental isolate of Pseudomonas aeruginosa MCCB 123 in fungal DNA extraction.","date":"2014","source":"Indian journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24617020","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40384857","id":"PMC_40384857","title":"SIRT4 Controls Acetyl-CoA Synthesis to Promote Stemness and Invasiveness of Hepatocellular Carcinoma through Deacetylating MCCC2.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40384857","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33423264","id":"PMC_33423264","title":"[Analysis of MCCC2 gene variant in a pedigree affected with 3-methylcrotonyl coenzyme A carboxylase deficiency].","date":"2021","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33423264","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40459729","id":"PMC_40459729","title":"Prospects of Synthetic Biology-Based Approaches in the Enhanced Production of Pyocyanin in Pseudomonas aeruginosa MCCB 117 as the Drug of Choice in Aquaculture.","date":"2025","source":"Current microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/40459729","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41836158","id":"PMC_41836158","title":"Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signaling.","date":"2026","source":"Breast cancer (Dove Medical Press)","url":"https://pubmed.ncbi.nlm.nih.gov/41836158","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40044138","id":"PMC_40044138","title":"Functional importance of Ser323 in cysteine desulfhydrase and cystathionine gamma-lyase MccB of Staphylococcus aureus.","date":"2025","source":"Journal of microbiology (Seoul, Korea)","url":"https://pubmed.ncbi.nlm.nih.gov/40044138","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.31.25324806","title":"Efficacy and Safety of Transcranial Temporal Interference Stimulation for Improving Negative Symptoms and Cognition in Schizophrenia: A Pilot Study","date":"2025-04-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.31.25324806","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.24.25322813","title":"Randomized Double Blind Inpatient Study of a Gluten-Free Diet in Persons with Schizophrenia","date":"2025-02-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.24.25322813","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.05.13.593989","title":"Engineered reactivity of a bacterial E1-like enzyme enables ATP-driven modification of protein C termini","date":"2024-05-13","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.13.593989","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26871637","id":"PMC_26871637","title":"Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26871637","citation_count":423,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21642987","id":"PMC_21642987","title":"IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA.","date":"2011","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21642987","citation_count":405,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22869039","id":"PMC_22869039","title":"Structure and function of biotin-dependent carboxylases.","date":"2012","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/22869039","citation_count":317,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27342126","id":"PMC_27342126","title":"Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27342126","citation_count":306,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28611215","id":"PMC_28611215","title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28611215","citation_count":282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15146197","id":"PMC_15146197","title":"Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15146197","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21532586","id":"PMC_21532586","title":"WWP2 is an E3 ubiquitin ligase for PTEN.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21532586","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23752268","id":"PMC_23752268","title":"The functional interactome landscape of the human histone deacetylase family.","date":"2013","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/23752268","citation_count":235,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27499296","id":"PMC_27499296","title":"Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27499296","citation_count":220,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30804502","id":"PMC_30804502","title":"H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30804502","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20186120","id":"PMC_20186120","title":"A functional peptidyl-tRNA hydrolase, ICT1, has been recruited into the human mitochondrial ribosome.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20186120","citation_count":153,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19380743","id":"PMC_19380743","title":"Charting the molecular network of the drug target Bcr-Abl.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19380743","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29117863","id":"PMC_29117863","title":"RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination.","date":"2017","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/29117863","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33087562","id":"PMC_33087562","title":"Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33087562","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35140242","id":"PMC_35140242","title":"Human transcription factor protein interaction networks.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35140242","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28718761","id":"PMC_28718761","title":"The human cytoplasmic dynein interactome reveals novel activators of motility.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28718761","citation_count":118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26725010","id":"PMC_26725010","title":"KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26725010","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33545068","id":"PMC_33545068","title":"Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33545068","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14064,"output_tokens":1815,"usd":0.034709},"stage2":{"model":"claude-opus-4-6","input_tokens":5068,"output_tokens":1970,"usd":0.111885},"total_usd":0.352514,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":25850,"output_tokens":3448,"usd":0.064635},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6113,"output_tokens":2545,"usd":0.141285}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"MCCC2 (MCCB) encodes the non-biotin-containing beta-subunit of 3-methylcrotonyl-CoA carboxylase (MCC), a mitochondrial enzyme involved in leucine catabolism; mutations in MCCC2 cause almost total loss of MCC enzyme activity in fibroblasts, establishing MCCC2 as a catalytically essential subunit.\",\n      \"method\": \"cDNA cloning, patient mutation identification, enzyme activity assay in fibroblasts\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original cloning paper with direct enzyme activity measurements in patient fibroblasts, replicated across multiple patients\",\n      \"pmids\": [\"11406611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Missense mutations in MCCC2 (MCCB) mapping to evolutionarily conserved residues result in null or severely diminished MCC carboxylase activity when expressed in SV40-transformed deficient fibroblasts, confirming their pathogenic effect and the functional importance of these residues.\",\n      \"method\": \"Transient transfection of patient-derived mutations into SV40-transformed fibroblasts, enzyme activity assay\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional reconstitution by transient transfection with direct enzyme activity readout\",\n      \"pmids\": [\"14680978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MCCC2 knockdown in HCC cells impairs leucine metabolism, reduces acetyl-CoA levels (a product of leucine catabolism), suppresses aerobic glycolysis markers (glucose consumption, lactate secretion), and abolishes the proliferative/migratory response to leucine deprivation, placing MCCC2 in the leucine-to-acetyl-CoA metabolic axis that feeds glycolysis and ERK activation.\",\n      \"method\": \"siRNA knockdown, CRISPR-sgRNA knockout, CCK-8 proliferation assay, transwell migration/invasion assay, metabolite measurement, mass spectrometry interactome profiling, flow cytometry\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple functional assays and metabolite measurements in a single lab; pathway placement supported by leucine deprivation epistasis\",\n      \"pmids\": [\"33407468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MCCC2 forms a protein complex with the telomere-binding protein TRF2 (detected by co-immunoprecipitation), and MCCC2 knockdown or knockout reduces telomere length without affecting telomerase (TERT) expression or activity, identifying a novel non-enzymatic role of MCCC2 in telomere maintenance.\",\n      \"method\": \"Co-immunoprecipitation, telomere length measurement, TERT activity assay, MCCC2 KD/KO with phenotypic readout\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP plus functional phenotype in single lab; novel finding with multiple orthogonal readouts\",\n      \"pmids\": [\"37828426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ECHDC2 promotes ubiquitination and proteasomal degradation of MCCC2 protein by binding with the E3 ubiquitin ligase NEDD4, thereby reducing MCCC2 levels and suppressing P38 MAPK pathway activation, aerobic glycolysis, and cancer cell proliferation.\",\n      \"method\": \"Co-immunoprecipitation, Western blotting, immunofluorescence, colony formation and CCK8 assays, glucose/lactate measurements, in vivo xenograft\",\n      \"journal\": \"Molecular medicine (Cambridge, Mass.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reciprocal Co-IP identifying ECHDC2/NEDD4/MCCC2 complex, functional rescue experiments, single lab\",\n      \"pmids\": [\"38783226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SIRT4 directly deacetylates MCCC2 at lysine 269, which promotes formation of a stable MCCC1/MCCC2 heterodimer with enhanced MCC enzymatic activity, leading to increased acetyl-CoA production, elevated H3K27 acetylation, and stem cell-like properties in HCC tumor-initiating cells.\",\n      \"method\": \"In vitro deacetylation assay, site-directed mutagenesis (K269), Co-immunoprecipitation, enzyme activity assay, histone acetylation measurement, in vivo tumor growth\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct identification of deacetylation site by mutagenesis, functional validation of complex activity and downstream epigenetic output in single study with multiple orthogonal methods\",\n      \"pmids\": [\"40384857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"MCCC2 knockdown in triple-negative breast cancer cells inhibits mTOR signaling in a leucine-dependent manner; leucine deprivation abolishes the effects of MCCC2 knockdown and rapamycin reverses them, placing MCCC2 upstream of mTOR activation in the leucine catabolism pathway.\",\n      \"method\": \"siRNA knockdown, rapamycin pharmacological inhibition, leucine deprivation epistasis, proliferation/migration/invasion assays, bioinformatic pathway analysis\",\n      \"journal\": \"Breast cancer (Dove Medical Press)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — genetic and pharmacological epistasis placing MCCC2 upstream of mTOR in leucine-dependent signaling, single lab\",\n      \"pmids\": [\"41836158\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MCCC2 encodes the non-biotin beta-subunit of the mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC) heterodimer that catabolizes leucine; SIRT4 directly deacetylates MCCC2 at K269 to stabilize the MCCC1/MCCC2 complex and boost MCC enzymatic activity and acetyl-CoA production, while MCCC2 protein levels are regulated by NEDD4-mediated ubiquitination promoted by ECHDC2, and MCCC2 additionally interacts with the telomere-binding protein TRF2 to maintain telomere length and activates mTOR signaling in a leucine-dependent manner in cancer cells.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries from KEEP papers.\n\n**Classification:**\n\nKEEP (about canonical human MCCC2/MCCB protein):\n- [1] PMID:16835865 — MCCD/MCCB mutations in newborn screening\n- [3] PMID:11406611 — Cloning of human MCCA and MCCB genes\n- [5] PMID:22264772 — Single mutation in MCCC1 or MCCC2\n- [7] PMID:33407468 — MCCC2 in HCC/leucine metabolism\n- [8] PMID:38783226 — ECHDC2/NEDD4/MCCC2 in gastric cancer\n- [9] PMID:14680978 — Functional analysis of MCCA/MCCB mutations\n- [11] PMID:37828426 — MCCC2 in colorectal cancer/telomere\n- [14] PMID:21071250 — Novel MCCA/MCCB mutations\n- [18] PMID:40384857 — SIRT4 deacetylates MCCC2\n- [19] PMID:33423264 — MCCC2 gene variant analysis\n- [21] PMID:41836158 — MCCC2 in TNBC/mTOR\n- gene2pubmed [14] PMID:22869039 — Structure/function of biotin-dependent carboxylases including MCC\n\nEXCLUDE (alias collision — different MccB/MCCB organisms, or unrelated MCCB-labeled microbes):\n- [2] PMID:19494832 — MccB = E. coli antibiotic biosynthesis enzyme (unrelated)\n- [4] PMID:30026096 — MCCB 281 = Bacillus cereus strain name (not gene)\n- [6] PMID:27868364 — MCCB 284 = Vibrio harveyi strain name\n- [10] PMID:32302772 — MCCB 110 = Nocardiopsis strain name\n- [12] PMID:33548322 — MCCB 281 = Bacillus cereus strain name\n- [13] PMID:28401470 — MCCB 248 = Streptomyces strain name\n- [15] PMID:17465309 — MCCB 114/115 = Synechocystis strain names\n- [16] PMID:34015495 — MCCB 110 = Nocardiopsis strain name\n- [17] PMID:24617020 — MCCB 123 = Pseudomonas strain name\n- [20] PMID:40459729 — MCCB 117 = Pseudomonas strain name\n- [22] PMID:40044138 — MccB = S. aureus PLP enzyme (unrelated)\n- [23] bio_10.1101_2025.03.31.25324806 — MCCB = cognitive battery score\n- [24] bio_10.1101_2025.02.24.25322813 — MCCB = cognitive battery score\n- [25] bio_10.1101_2024.05.13.593989 — MccB = E. coli E1-like enzyme (unrelated)\n- gene2pubmed [1]-[13],[15]-[30] — Large-scale genomics/proteomics or unrelated proteins\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"The human MCCB (MCCC2) gene, located on chromosome 5q13 and comprising 17 exons, encodes the 563-amino acid non-biotin-containing beta-subunit of 3-methylcrotonyl-CoA carboxylase (MCC). Missense mutations in MCCB (R268T and E99Q) cause an almost total loss of MCC enzyme activity in fibroblasts, establishing MCCC2 as a disease-causing gene for 3-methylcrotonyl-CoA carboxylase deficiency.\",\n      \"method\": \"cDNA cloning, chromosomal mapping, Sanger sequencing of patient alleles, enzyme activity assay in fibroblasts\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original cloning with direct enzyme activity measurement in patient fibroblasts\",\n      \"pmids\": [\"11406611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Missense mutations in MCCB (MCCC2) at evolutionarily conserved residues cause null or severely diminished MCC carboxylase activity when expressed by transient transfection in SV40-transformed MCC-deficient fibroblasts, directly confirming their pathogenicity. Structural homology modelling to E. coli acetyl-CoA carboxylase biotin carboxylase subunit was used to rationalise the effect of MCCA mutations, indicating the MCC holoenzyme shares conserved active-site architecture.\",\n      \"method\": \"Transient transfection of patient-derived missense mutations into MCC-deficient fibroblasts, MCC enzyme activity assay, 3D homology modelling\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional rescue/loss assay in relevant cell system with direct enzymatic readout\",\n      \"pmids\": [\"14680978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Crystal structures of MCC holoenzyme (containing both MCCC1/alpha and MCCC2/beta subunits) revealed an unanticipated domain architecture including previously unrecognized domains, and provided a molecular basis for understanding the two-step carboxylation catalytic mechanism of the biotin-dependent carboxylase as well as the structural basis for a large collection of disease-causing mutations in the MCCC2 beta (carboxyltransferase) subunit.\",\n      \"method\": \"Crystal structure determination of MCC holoenzyme, structure-function analysis of disease mutations\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystallographic structure of MCC holoenzyme with mechanistic and mutational validation, review of multiple structures\",\n      \"pmids\": [\"22869039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MCCC2 promotes hepatocellular carcinoma (HCC) cell proliferation, migration, and invasion in vitro and tumor growth in vivo. MCCC2 supports leucine metabolism: HCC cells lacking MCCC2 fail to respond to leucine deprivation (proliferation/migration inhibition seen in MCCC2-present but not MCCC2-absent cells), and MCCC2 knockdown reduces glycolysis markers (glucose consumption, lactate secretion) and acetyl-CoA levels. Mass spectrometry-based interactome profiling revealed MCCC2-associated proteins enriched in protein metabolism and energy pathways. MCCC2 promotes ERK activation.\",\n      \"method\": \"MCCC2 sgRNA knockout, siRNA knockdown, CCK-8 proliferation assay, transwell migration/invasion assay, flow cytometry, xenograft in vivo, leucine deprivation experiments, mass spectrometry interactome profiling, western blot for ERK, metabolite measurements\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO/KD with defined cellular phenotypes and metabolic readouts in vitro and in vivo, but ERK activation mechanistic link is indirect\",\n      \"pmids\": [\"33407468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MCCC2 forms a protein complex with the telomere-binding protein TRF2, as shown by co-immunoprecipitation. MCCC2 knockdown or knockout reduces mitochondrial numbers (without affecting gross ATP production), upregulates mitochondrial fusion markers MFN1, MFN2, and OPA1 (indicating increased mitochondrial fusion), and reduces telomere length without affecting telomerase (TERT) expression or activity, identifying MCCC2 as a novel mediator between mitochondria and telomeres.\",\n      \"method\": \"Co-immunoprecipitation (MCCC2/TRF2 complex), MCCC2 KD/KO in colorectal cancer cells, transmission electron microscopy (mitochondrial morphology), western blot (MFN1, MFN2, OPA1, TERT), telomere length measurement, telomerase activity assay, xenograft in vivo\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP interaction with TRF2 and multi-phenotype KD/KO characterization, single lab\",\n      \"pmids\": [\"37828426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ECHDC2 promotes ubiquitination and proteasomal degradation of MCCC2 protein by physically binding the E3 ubiquitin ligase NEDD4, which ubiquitinates MCCC2. This degradation of MCCC2 suppresses the P38 MAPK pathway, reducing aerobic glycolysis and proliferation in gastric cancer cells. Co-immunoprecipitation confirmed the ECHDC2–NEDD4–MCCC2 ternary interaction.\",\n      \"method\": \"Co-immunoprecipitation (ECHDC2, NEDD4, MCCC2), western blot (ubiquitination assay, P38 MAPK pathway), ECHDC2 overexpression in gastric cancer cells, colony formation/CCK8/EDU proliferation assays, glucose/lactic acid assays, subcutaneous tumor experiments in nude mice, immunofluorescence\",\n      \"journal\": \"Molecular medicine (Cambridge, Mass.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP of ternary complex with ubiquitination assay and functional pathway readout, single lab\",\n      \"pmids\": [\"38783226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SIRT4 directly deacetylates MCCC2 at lysine 269 (K269), which promotes formation of a stable MCCC1/MCCC2 heterodimeric complex with robust MCC enzymatic activity, leading to increased acetyl-CoA production. This elevated acetyl-CoA results in increased H3K27 acetylation and stem cell-like (tumor-initiating cell) properties and invasiveness in HCC cells. SIRT4 expression is upregulated by α2δ1-mediated calcium signaling.\",\n      \"method\": \"Deacetylation assay (SIRT4 acting on MCCC2-K269), co-immunoprecipitation (MCCC1/MCCC2 complex stability), acetyl-CoA measurement, H3K27 acetylation assay, tumor-initiating cell sphere assays, invasion assays, in vivo tumor growth assay, site-directed mutagenesis (K269 acetylation site)\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — direct PTM identification with mutagenesis and multiple functional readouts, single lab\",\n      \"pmids\": [\"40384857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"MCCC2 knockdown in triple-negative breast cancer (TNBC) cells inhibits proliferation, migration, invasion, and tumor growth. The inhibitory effect of MCCC2 knockdown is reversed by rapamycin (mTOR inhibitor) and abolished under leucine-free culture conditions, indicating that MCCC2 promotes TNBC progression by activating mTOR signaling in a leucine-dependent manner.\",\n      \"method\": \"MCCC2 siRNA knockdown in TNBC cell lines, proliferation/migration/invasion assays, xenograft tumor growth, rapamycin combination treatment, leucine deprivation experiments, bioinformatic pathway analysis (CPTAC database)\",\n      \"journal\": \"Breast cancer (Dove Medical Press)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KD with pharmacological and nutrient-deprivation epistasis establishing leucine-mTOR axis, single lab\",\n      \"pmids\": [\"41836158\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MCCC2 (MCCB) encodes the non-biotin-containing beta (carboxyltransferase) subunit of the mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC) heterodimer, which catabolizes leucine; its enzymatic activity depends on formation of a stable complex with the MCCC1 alpha-subunit (promoted by SIRT4-mediated deacetylation at K269), and MCCC2 drives cancer cell proliferation and invasion by sustaining leucine-dependent acetyl-CoA production, mTOR signaling, and ERK activation, while being subject to NEDD4-mediated ubiquitin-proteasomal degradation facilitated by ECHDC2, and additionally interacting with telomere-binding protein TRF2 to influence mitochondrial dynamics and telomere maintenance.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MCCC2 encodes the non-biotin-containing beta-subunit of mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC), a heterodimeric enzyme essential for leucine catabolism and acetyl-CoA production. Mutations in MCCC2 abolish MCC carboxylase activity, causing 3-methylcrotonylglycinuria [PMID:11406611, PMID:14680978]. MCC enzymatic activity is regulated post-translationally: SIRT4 deacetylates MCCC2 at K269 to stabilize the MCCC1/MCCC2 heterodimer and enhance catalytic output [PMID:40384857], while ECHDC2 recruits the E3 ligase NEDD4 to ubiquitinate and degrade MCCC2 [PMID:38783226]. Beyond its metabolic role, MCCC2-dependent leucine catabolism feeds into mTOR signaling and aerobic glycolysis in cancer cells [PMID:33407468, PMID:41836158], and MCCC2 interacts with the telomere-binding protein TRF2 to maintain telomere length independently of telomerase [PMID:37828426].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of MCCC2 as the gene encoding the non-biotin beta-subunit of MCC resolved the molecular basis of isolated 3-methylcrotonylglycinuria and established that MCCC2 is catalytically essential for leucine catabolism.\",\n      \"evidence\": \"cDNA cloning combined with mutation identification and MCC enzyme activity assays in patient fibroblasts\",\n      \"pmids\": [\"11406611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structural basis of MCCC1–MCCC2 heterodimer assembly unknown\", \"no reconstitution of purified recombinant MCC complex\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Functional expression of patient-derived MCCC2 missense mutations in deficient fibroblasts demonstrated that specific conserved residues are required for carboxylase activity, establishing genotype–activity relationships.\",\n      \"evidence\": \"transient transfection of mutant MCCC2 constructs into SV40-transformed fibroblasts with enzyme activity measurement\",\n      \"pmids\": [\"14680978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"no crystal structure to explain residue-level loss of activity\", \"no assessment of protein stability vs. catalytic deficiency for individual mutations\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placing MCCC2 in a leucine-to-acetyl-CoA metabolic axis that feeds aerobic glycolysis and ERK activation in hepatocellular carcinoma revealed how leucine catabolism via MCC supports cancer cell proliferation and migration.\",\n      \"evidence\": \"siRNA/CRISPR knockout in HCC cells with metabolite quantification, proliferation and migration assays, and leucine deprivation epistasis\",\n      \"pmids\": [\"33407468\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"mechanism connecting acetyl-CoA to ERK activation not fully delineated\", \"findings limited to HCC cell lines in single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery that MCCC2 physically interacts with TRF2 and is required for telomere length maintenance—independently of telomerase—uncovered an unexpected non-metabolic function for this enzyme subunit.\",\n      \"evidence\": \"co-immunoprecipitation of MCCC2–TRF2, telomere length measurement after MCCC2 KD/KO\",\n      \"pmids\": [\"37828426\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"single Co-IP without reciprocal validation or domain mapping\", \"mechanism by which MCCC2 sustains telomere length is unknown\", \"not independently replicated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of ECHDC2/NEDD4-mediated ubiquitination as a degradation pathway for MCCC2 protein revealed a post-translational mechanism that tunes MCC levels and downstream P38 MAPK/glycolysis signaling in cancer.\",\n      \"evidence\": \"reciprocal Co-IP of ECHDC2–NEDD4–MCCC2, proteasome inhibitor rescue, xenograft growth assays\",\n      \"pmids\": [\"38783226\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"specific ubiquitination sites on MCCC2 not mapped\", \"whether NEDD4-mediated degradation operates in normal tissues is untested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstration that SIRT4 deacetylates MCCC2 at K269 to stabilize the MCCC1/MCCC2 dimer and boost MCC activity provided a direct regulatory mechanism linking mitochondrial sirtuin signaling to leucine catabolism and downstream histone acetylation.\",\n      \"evidence\": \"in vitro deacetylation assay, K269 site-directed mutagenesis, Co-IP, enzyme activity and H3K27ac measurement in HCC tumor-initiating cells\",\n      \"pmids\": [\"40384857\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"acetyltransferase responsible for K269 acetylation not identified\", \"whether K269 regulation occurs in non-cancerous tissues unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Epistasis experiments with leucine deprivation and rapamycin placed MCCC2 upstream of mTOR activation in breast cancer, extending the metabolic signaling role of MCCC2 beyond HCC and identifying mTOR as a downstream effector of leucine catabolism.\",\n      \"evidence\": \"siRNA knockdown in triple-negative breast cancer cells, rapamycin rescue, leucine deprivation epistasis\",\n      \"pmids\": [\"41836158\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"direct metabolite intermediary linking MCC activity to mTOR activation unidentified\", \"single lab and cell type\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of the MCCC1/MCCC2 heterodimer, the mechanism by which MCCC2 maintains telomere length, and the identity of the acetyltransferase that acetylates K269 remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"no high-resolution structure of the human MCC holoenzyme\", \"TRF2 interaction domain on MCCC2 not mapped\", \"metabolite signal connecting leucine catabolism to mTOR not identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 1, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 6]}\n    ],\n    \"complexes\": [\n      \"3-methylcrotonyl-CoA carboxylase (MCCC1/MCCC2)\"\n    ],\n    \"partners\": [\n      \"MCCC1\",\n      \"SIRT4\",\n      \"TRF2\",\n      \"NEDD4\",\n      \"ECHDC2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"MCCC2 encodes the non-biotin-containing carboxyltransferase (beta) subunit of mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC), which catalyzes an essential step in leucine catabolism and whose crystal structure reveals a conserved two-step carboxylation mechanism [PMID:22869039]. Missense mutations in MCCC2 abolish MCC enzyme activity and cause 3-methylcrotonyl-CoA carboxylase deficiency [PMID:11406611, PMID:14680978]. Formation of a catalytically competent MCCC1–MCCC2 heterodimer is promoted by SIRT4-mediated deacetylation of MCCC2 at K269, linking leucine-derived acetyl-CoA production to H3K27 acetylation and tumor-initiating cell properties, while MCCC2 protein turnover is governed by NEDD4-mediated ubiquitin-proteasomal degradation facilitated by ECHDC2 [PMID:40384857, PMID:38783226]. In cancer cells, MCCC2 sustains proliferation and invasion through leucine-dependent activation of mTOR and ERK signaling pathways and influences mitochondrial dynamics and telomere length via interaction with TRF2 [PMID:33407468, PMID:41836158, PMID:37828426].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of MCCC2 as the gene encoding the beta subunit of MCC and demonstration that its mutations cause 3-methylcrotonyl-CoA carboxylase deficiency established the molecular basis of this inborn error of leucine metabolism.\",\n      \"evidence\": \"cDNA cloning, chromosomal mapping, Sanger sequencing of patient alleles, and MCC enzyme activity assay in fibroblasts\",\n      \"pmids\": [\"11406611\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of how beta-subunit mutations disrupt holoenzyme function was unknown\",\n        \"Regulation of MCCC2 protein levels and post-translational modifications were uncharacterized\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Functional expression of patient-derived MCCC2 missense mutations in MCC-deficient fibroblasts directly confirmed their pathogenicity and showed that conserved residues in the carboxyltransferase subunit are essential for catalytic activity.\",\n      \"evidence\": \"Transient transfection of mutant MCCC2 into SV40-transformed MCC-deficient fibroblasts with direct MCC enzyme activity readout\",\n      \"pmids\": [\"14680978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of the holoenzyme was available to map mutation effects\",\n        \"Genotype–phenotype correlations across the full mutation spectrum remained incomplete\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Crystal structures of the MCC holoenzyme revealed the domain architecture of the MCCC2 beta subunit and provided a structural framework for the two-step carboxylation mechanism and for rationalizing disease-causing mutations.\",\n      \"evidence\": \"X-ray crystallography of the MCCC1–MCCC2 holoenzyme with structure–function analysis of known mutations\",\n      \"pmids\": [\"22869039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Post-translational regulation of complex assembly was not addressed\",\n        \"Non-catalytic roles of MCCC2 in cellular signaling were unknown\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating that MCCC2 promotes hepatocellular carcinoma cell proliferation, invasion, and ERK activation through leucine metabolism and acetyl-CoA production expanded its role beyond a housekeeping enzyme to an oncogenic metabolic node.\",\n      \"evidence\": \"MCCC2 KO/KD in HCC cells, xenograft models, leucine deprivation epistasis, metabolite measurements, mass spectrometry interactome, ERK western blot\",\n      \"pmids\": [\"33407468\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct mechanism linking MCCC2-derived acetyl-CoA to ERK activation was not delineated\",\n        \"Whether the oncogenic role is generalizable across tumor types was untested\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery of a physical MCCC2–TRF2 complex and the finding that MCCC2 loss reduces mitochondrial numbers and telomere length suggested an unexpected role linking mitochondrial dynamics to telomere maintenance.\",\n      \"evidence\": \"Co-immunoprecipitation of MCCC2 and TRF2, MCCC2 KD/KO in colorectal cancer cells, TEM for mitochondrial morphology, telomere length measurement\",\n      \"pmids\": [\"37828426\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Co-IP was performed in a single lab without reciprocal validation from an independent group\",\n        \"Mechanism by which MCCC2 influences telomere length independently of telomerase is unknown\",\n        \"Whether TRF2 interaction requires MCCC2 enzymatic activity was not tested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of NEDD4 as the E3 ligase that ubiquitinates MCCC2 — facilitated by ECHDC2 as an adaptor — established the first defined mechanism for MCCC2 protein turnover and linked MCCC2 stability to P38 MAPK-dependent aerobic glycolysis in gastric cancer.\",\n      \"evidence\": \"Co-immunoprecipitation of ECHDC2–NEDD4–MCCC2 ternary complex, ubiquitination assays, ECHDC2 overexpression in gastric cancer cells, in vivo xenografts\",\n      \"pmids\": [\"38783226\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific ubiquitination sites on MCCC2 were not mapped\",\n        \"Whether NEDD4-mediated degradation operates in non-cancer tissues is unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"SIRT4-mediated deacetylation of MCCC2 at K269 was shown to promote stable MCCC1–MCCC2 complex formation, increasing MCC activity, acetyl-CoA output, and downstream H3K27 acetylation that drives tumor-initiating cell properties in HCC.\",\n      \"evidence\": \"In vitro deacetylation assay, K269 site-directed mutagenesis, co-IP for complex stability, acetyl-CoA and H3K27ac measurements, sphere-forming and invasion assays, in vivo tumor growth\",\n      \"pmids\": [\"40384857\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether K269 acetylation status regulates MCCC2 stability via the NEDD4 pathway was not examined\",\n        \"Physiological relevance of SIRT4-MCCC2 axis in normal leucine catabolism remains untested\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Epistasis experiments in triple-negative breast cancer demonstrated that MCCC2-driven proliferation depends on leucine availability and mTOR signaling, consolidating the leucine–mTOR axis as the dominant oncogenic mechanism downstream of MCCC2.\",\n      \"evidence\": \"MCCC2 siRNA KD in TNBC cells, rapamycin rescue, leucine-free culture abrogation of phenotype, xenograft tumor growth\",\n      \"pmids\": [\"41836158\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct biochemical link between MCCC2-derived metabolites and mTOR activation (e.g., leucine sensing machinery) is not resolved\",\n        \"Contribution of MCCC2 catalytic activity versus scaffolding functions to mTOR activation is unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The integration of MCCC2 post-translational regulation (SIRT4 deacetylation versus NEDD4 ubiquitination) with its non-canonical roles in telomere maintenance and mitochondrial dynamics remains mechanistically unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No reconstitution of the MCCC2–TRF2 axis in a non-cancer or physiological model\",\n        \"How MCCC2 K269 acetylation cross-talks with NEDD4-mediated ubiquitination is unknown\",\n        \"Structural basis for non-catalytic protein–protein interactions of MCCC2 is lacking\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 2, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 3, 6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 5, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 7]}\n    ],\n    \"complexes\": [\n      \"3-methylcrotonyl-CoA carboxylase (MCCC1–MCCC2 heterodimer)\"\n    ],\n    \"partners\": [\n      \"MCCC1\",\n      \"SIRT4\",\n      \"TRF2\",\n      \"NEDD4\",\n      \"ECHDC2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}